Viewing Study NCT00752518

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:01 AM

Ignite Modification Date: 2025-12-26 @ 4:02 AM

Study NCT ID: NCT00752518

Status: COMPLETED

Last Update Posted: 2011-05-17

First Post: 2008-09-11

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients

Sponsor: Janssen Pharmaceutical K.K.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module